drugset / Trial / NCT04007224
Umbilical Cord Blood vs Personalized Treatments for Improving Autistic Disorder
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The clinical study evaluates in an open-label, crossover design the comparative efficacy and safety of intranasal oxytocin and autologous umbilical cord blood for improving the functioning of children with autistic spectrum disorder
Timeline
- Start
- 2019-01-17
- Primary completion
- 2023-06-28
- Completion
- 2023-07-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Autologous cord blood | Cell therapy | — | Intravenous |
| Comparator | Oxytocin | Peptide | 5 iu | Intranasal |
| Comparator | Oxytocin | Peptide | 10 iu | Intranasal |
| Comparator | Curcumin | Small molecule | 250 mg | Oral |
| Comparator | lecithin | Unknown | 500 mg | — |
| Comparator | pironoquinolinquinone | Unknown | 20 mg | — |